Our previous study revealed that the co-inhibitory TIGIT axis may be involved in the regulation of Foxp3+ γδ Treg cells and indicate the clinical progression and prognosis of AML patients with different clinical statuses (48, 49). Here, TIGIT is linked to acute myeloid leukemia.